Industry News 2019-02-14T03:28:07+00:00

Industry News

News & Statements

The Digital Therapeutics Alliance convenes thought leaders from across the industry – including DTx companies, patients, healthcare providers, payers, and industry partners – to establish foundational best practices and frameworks related to DTx product validation, operations, value, and regulatory oversight.

DTA Launches Payer Advisory Group

The Digital Therapeutics Alliance is pleased to launch our Healthcare Payer Advisory Group. We are seeking global engagement from individuals who have experience working within healthcare decision maker and payer settings. Advisory Group members will [...]

DTA Welcomes Applications for Strategic Advisors

The Digital Therapeutics Alliance announces the opening of the application process for our cohort of 2019-20 Strategic Advisors. We are looking to engage with individuals from across the global healthcare landscape who will provide unique [...]

Digital Therapeutics Need Quality Standards

Forbes (Greg Licholai) - Quality standards are necessary to help promote adoption of the novel class of interventions called digital therapeutics. This rapidly emerging industry needs to bring together regulators, engineers, practitioners, and companies to [...]

Load More Posts

Industry Insights

Digital therapeutics form an independent category of evidence-based products within the broader digital health landscape. These products are distinguished from other digital health categories by their primary function of delivering software-generated therapeutic interventions directly to patients to prevent, manage, or treat a medical disorder or disease. DTx products will increasingly influence the way healthcare is delivered and consumed across the world.

Load More Posts

DTx Research & Studies

Digital therapeutics present the market with evidence-based technologies that have the ability to elevate medical best practices, address unmet medical needs, expand healthcare access, and improve clinical and health economic outcomes.

Impact of a digital health intervention on asthma resource utilization

Digital health interventions have been associated with reduced rescue inhaler use and improved controller medication adherence. This quality improvement project assessed the benefit of these interventions on asthma-related healthcare utilizations, including hospitalizations, emergency department (ED) [...]

Use of Digital Health Technology to Enable Drug Development

This pilot study developed and evaluated the feasibility, usability, and perceived satisfaction with an end-user mobile medical application and provider web portal. The two interfaces allowed for remote monitoring, provided daily guidance in the management [...]

Load More Posts

Stay Up To Date

SIGN UP FOR DTA NEWS & UPDATES

Sign Up Now